Home > Financial Ratios > BIOCON

BIOCON
Working Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 5.477.86-83.122.951.80

What is the latest Working Capital/Sales ratio of BIOCON ?

The latest Working Capital/Sales ratio of BIOCON is 5.47 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20265.47
Mar20257.86
Mar2024-83.12
Mar20232.95
Mar20221.80

How is Working Capital/Sales of BIOCON Trending?

Years Working Capital/Sales % Change
Mar2026 5.47
-30.41
Mar2025 7.86
Positive
Mar2024 -83.12
Negative
Mar2023 2.95
63.89
Mar2022 1.8 -

Other Financial Ratios of BIOCON


Compare Working Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹64,234.6 Cr 3.7% -3.9% 9.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.1% -2.4% 13.8% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 2.7% 12.9% 54.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 1.8% 2.5% 40.9% Stock Analytics
CIPLA ₹111,484.0 Cr 0.6% -3.8% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 3.3% 1.3% -7.6% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

3.7%

-3.9%

9.8%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses